{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:41Z","timestamp":1790632601885,"version":"4.1.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/iae.0b013e3182993d74","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T12:29:48Z","timestamp":1373459388000},"page":"352-359","source":"Crossref","is-referenced-by-count":27,"title":["PENTRAXIN 3 AND OTHER INFLAMMATORY FACTORS IN CENTRAL RETINAL VEIN OCCLUSION AND MACULAR EDEMA"],"prefix":"10.1097","volume":"34","author":[{"given":"Hidetaka","family":"Noma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Masahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210130","first-page":"793","article-title":". In vivo evaluation of leukocyte dynamics in retinal ischemia reperfusion injury.","volume":"39","author":"Tsujikawa","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-17-20210130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":". A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R3-17-20210130","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0161-6420(92)31875-5","article-title":"Blood-aqueous barrier in eyes with retinal vein occlusion.","volume":"99","author":"Miyake","year":"1992","journal-title":"Ophthalmology"},{"key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000313819","article-title":"Visual acuity and foveal thickness after vitrectomy for macular edema.","volume":"224","author":"Noma","year":"2010","journal-title":"Ophthalmologica"},{"key":"R5-17-20210130","first-page":"1808","article-title":". VEGF increases retinal vascular ICAM-1 expression in vivo.","volume":"40","author":"Lu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-17-20210130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.05-4313fje","article-title":". Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.","volume":"20","author":"Zhang","year":"2006","journal-title":"FASEB J"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"e8158","DOI":"10.1371\/journal.pone.0008158","article-title":". Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.","volume":"4","author":"Yoshimura","year":"2009","journal-title":"PLoS One"},{"key":"R8-17-20210130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2008.09.034","article-title":". Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.","volume":"116","author":"Noma","year":"2009","journal-title":"Ophthalmology"},{"key":"R9-17-20210130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/02713683.2010.513090","article-title":". Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.","volume":"36","author":"Noma","year":"2011","journal-title":"Curr Eye Res"},{"key":"R10-17-20210130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10384-011-0016-4","article-title":". Vitreous inflammatory factors in macular edema with central retinal vein occlusion.","volume":"55","author":"Noma","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"R11-17-20210130","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","article-title":"F, dAniello EM, Golay J, et al.. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component.","volume":"267","year":"1992","journal-title":"J Biol Chem"},{"key":"R12-17-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R13-17-20210130","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":". PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans.","volume":"102","author":"Peri","year":"2000","journal-title":"Circulation"},{"key":"R14-17-20210130","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":". Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"R15-17-20210130","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":". Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes.","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"R16-17-20210130","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V87.5.1862.1862","article-title":". Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites.","volume":"87","author":"Introna","year":"1996","journal-title":"Blood"},{"key":"R17-17-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jlb.67.3.387","article-title":"Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages.","volume":"67","author":"Goodman","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R18-17-20210130","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.200324390","article-title":". Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells.","volume":"33","author":"Doni","year":"2003","journal-title":"Eur J Immunol"},{"key":"R19-17-20210130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2004.03.020","article-title":". Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells.","volume":"175","author":"Klouche","year":"2004","journal-title":"Atherosclerosis"},{"key":"R20-17-20210130","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1002\/j.1460-2075.1990.tb07897.x","article-title":". Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites.","volume":"9","author":"Toniatti","year":"1990","journal-title":"EMBO J"},{"key":"R21-17-20210130","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update.","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"R22-17-20210130","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0002-9440(10)61122-4","article-title":". Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury.","volume":"160","author":"Souza","year":"2002","journal-title":"Am J Pathol"},{"key":"R23-17-20210130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2353\/ajpath.2009.080240","article-title":". The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice.","volume":"174","author":"Souza","year":"2009","journal-title":"Am J Pathol"},{"key":"R24-17-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1002432032354","article-title":"Vitrectomy for macular edema combined with retinal vein occlusion.","volume":"97","author":"Tachi","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"R25-17-20210130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2415-5-10","article-title":". Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases.","volume":"5","author":"Leizaola-Fernandez","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"R26-17-20210130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/112067210601600609","article-title":". Long-term visual outcomes of vitrectomy for cystoid macular edema due to nonischemic central retinal vein occlusion.","volume":"16","author":"Furukawa","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"R27-17-20210130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.1993.01090080083022","article-title":"Baseline and early natural history report.","volume":"111","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R28-17-20210130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion.","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"R29-17-20210130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion.","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R30-17-20210130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ajo.2008.11.019","article-title":"Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes.","volume":"147","author":"Han","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R31-17-20210130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(99)00409-2","article-title":"Tomographic assessment of vitreous surgery for diabetic macular edema.","volume":"129","author":"Otani","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R32-17-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":". Association of vitreous inflammatory factors with diabetic macular edema.","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"R33-17-20210130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/bjo.2010.192468","article-title":". Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion.","volume":"95","author":"Noma","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R34-17-20210130","first-page":"1029","article-title":"Vascular permeability factorvascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am J Pathol"},{"key":"R35-17-20210130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.1854","article-title":". Regulation of leukocyte recruitment by the long pentraxin PTX3.","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"R36-17-20210130","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)65044-4","article-title":". Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).","volume":"156","author":"Miyamoto","year":"2000","journal-title":"Am J Pathol"},{"key":"R37-17-20210130","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1167\/iovs.02-0807","article-title":". VEGF164 is proinflammatory in the diabetic retina.","volume":"44","author":"Ishida","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R38-17-20210130","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/archopht.1995.01100120068012","article-title":". Hypoxic regulation of vascular endothelial growth factor in retinal cells.","volume":"113","author":"Aiello","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R39-17-20210130","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":". Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"R40-17-20210130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cardiores.2004.09.032","article-title":"Transcriptional regulation of the vascular endothelial growth factor genea concert of activating factors.","volume":"65","author":"Pages","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R41-17-20210130","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/344678a0","article-title":"Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.","volume":"344","author":"Ghosh","year":"1990","journal-title":"Nature"},{"key":"R42-17-20210130","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1172\/JCI119006","article-title":". Characterization of vascular endothelial growth factors effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.","volume":"98","author":"Xia","year":"1996","journal-title":"J Clin Invest"},{"key":"R43-17-20210130","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":". Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1KDR activation of c-Src.","volume":"274","author":"He","year":"1999","journal-title":"J Biol Chem"},{"key":"R44-17-20210130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1096\/fasebj.13.12.1593","article-title":". Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCgamma.","volume":"13","author":"Olivera","year":"1999","journal-title":"FASEB J"},{"key":"R45-17-20210130","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1074\/jbc.275.7.5096","article-title":". Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.","volume":"275","author":"Wu","year":"2000","journal-title":"J Biol Chem"},{"key":"R46-17-20210130","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1074\/jbc.272.13.8172","article-title":"Sica A, dAniello E, et al.. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation.","volume":"272","author":"Basile","year":"1997","journal-title":"J Biol Chem"},{"key":"R47-17-20210130","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1073\/pnas.0308342101","article-title":". Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.","volume":"101","author":"Liu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-17-20210130","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":". Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"R49-17-20210130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjo.2007.127282","article-title":". Intravitreal avastin for macular oedema secondary to retinal vein occlusion: a prospective study.","volume":"92","author":"Kriechbaum","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R50-17-20210130","first-page":"284","article-title":"Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion.","volume":"31","author":"Stefansson","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R51-17-20210130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2006.04.005","article-title":"Ocular oxygenation and the treatment of diabetic retinopathy.","volume":"51","author":"Stefansson","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"R53-17-20210130","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/112067210901900625","article-title":". Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion.","volume":"19","author":"Raszewska-Steglinska","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R54-17-20210130","first-page":"1089","article-title":". Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion.","volume":"5","author":"Baharivand","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R55-17-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2415-13-2","article-title":"Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case series.","volume":"13","author":"Noma","year":"2013","journal-title":"BMC Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e3182993d74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:46:28Z","timestamp":1620953188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201402000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3182993d74","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}